154 related articles for article (PubMed ID: 32004937)
1. Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
Bolteau R; Descamps F; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
Eur J Med Chem; 2020 Mar; 189():112078. PubMed ID: 32004937
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
[TBL] [Abstract][Full Text] [Related]
3. Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.
Rami M; Landagaray E; Ettaoussi M; Boukhalfa K; Caignard DH; Delagrange P; Berthelot P; Yous S
Molecules; 2012 Dec; 18(1):154-66. PubMed ID: 23262445
[TBL] [Abstract][Full Text] [Related]
4. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).
Ettaoussi M; Sabaouni A; Rami M; Boutin JA; Delagrange P; Renard P; Spedding M; Caignard DH; Berthelot P; Yous S
Eur J Med Chem; 2012 Mar; 49():310-23. PubMed ID: 22301214
[TBL] [Abstract][Full Text] [Related]
7. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist.
Ettaoussi M; Sabaouni A; Pérès B; Landagaray E; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
ChemMedChem; 2013 Nov; 8(11):1830-45. PubMed ID: 24031039
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
11. New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.
Ancizu S; Castrillo N; Pérez-Silanes S; Aldana I; Monge A; Delagrange P; Caignard DH; Galiano S
Molecules; 2012 Jun; 17(7):7737-57. PubMed ID: 22732886
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
Attia MI; Witt-Enderby PA; Julius J
Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
[TBL] [Abstract][Full Text] [Related]
14. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-arylfuro[3,2-b]pyridines: Effect of the C2-aryl group on melatoninergic activity.
Couhert A; Delagrange P; Caignard DH; Chartier A; Suzenet F; Guillaumet G
Eur J Med Chem; 2016 Feb; 109():268-75. PubMed ID: 26785296
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT
Duroux R; Rami M; Landagaray E; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
Eur J Med Chem; 2017 Dec; 141():552-566. PubMed ID: 29102176
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.
Koike T; Takai T; Hoashi Y; Nakayama M; Kosugi Y; Nakashima M; Yoshikubo S; Hirai K; Uchikawa O
J Med Chem; 2011 Jun; 54(12):4207-18. PubMed ID: 21568291
[TBL] [Abstract][Full Text] [Related]
18. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
Mésangeau C; Pérès B; Descamps-François C; Chavatte P; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Bennejean C; Renard P; Caignard DH; Berthelot P; Yous S
Bioorg Med Chem; 2010 May; 18(10):3426-36. PubMed ID: 20444610
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
Hu Y; Chan KH; He X; Ho MK; Wong YH
PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]